Breaking News Instant updates and real-time market news.

HZNP

Horizon Pharma

$21.49

-0.21 (-0.97%)

10:15
11/28/16
11/28
10:15
11/28/16
10:15

Horizon Pharma put volume heavy and directionally bearish

Bearish flow noted in Horizon Pharma with 11,089 puts trading, or 30x expected. Most active are Jan-17 14 puts and Jan-17 15 puts, with total volume in those strikes near 10,600 contracts. The Put/Call Ratio is 12.21, while ATM IV is up over 10 points on the day. Earnings are expected on February 28th.

  • 29

    Nov

  • 29

    Nov

  • 14

    Dec

HZNP Horizon Pharma
$21.49

-0.21 (-0.97%)

10/12/16
GSCO
10/12/16
NO CHANGE
Target $26
GSCO
Buy
Horizon Pharma risk/reward attractive, says Goldman
Goldman analyst Stephan Stewart lowered Horizon Pharma 2016-2020 EBITDA estimates 4%-7% largely due to increase in investments across its primary care and orphan franchises following the guidance update. Stewart said the investments fit with Horizon's ongoing transition toward higher growth orphan sales against a more sustainable primary care base. He also sees potential synergy upside from the pending Raptor deal as a source of some 2017 offset. The analyst lowered Horizon's price target to $26 from $27 but said risk/reward is attractive and reiterates his Buy rating.
10/27/16
PIPR
10/27/16
NO CHANGE
Target $33
PIPR
Overweight
Piper survey suggests growth for Horizon's Krystexxa
Piper Jaffray analyst David Amsellem says his survey of 25 rheumatologists who treat patients with chronic refractory gout and who are at least familiar with Horizon Pharma's Krystexxa suggest usage of the product is likely to broaden. The analyst points out that 76% of the respondents believe Krystexxa is a very effective option for the treatment of chronic refractory gout. He continues to believe Horizon is well positioned to deliver long-term annual earnings growth at least in the mid-teens. Amsellem sees an attractive valuation for Horizon shares and reiterates an Overweight rating on the name with a $33 price target.
11/28/16
SBSH
11/28/16
UPGRADE
Target $25
SBSH
Buy
Horizon Pharma upgraded to Buy from Neutral at Citi
Citi analyst Liav Abraham upgraded Horizon Pharma to Buy after resuming coverage of the name. The analyst views the risk/reward as favorable into the upcoming pivotal data for Actimmune in Friederich's Ataxia. The data are expected in late December. Abraham raised her price target for the shares to $25 from $21.
11/28/16
BMOC
11/28/16
NO CHANGE
BMOC
Horizon Pharma risk/reward positive into Phase 3 data, says BMO Capital
BMO Capital analyst Gary Nachman says that the risk/reward ratio for Horizon is positive going into the Phase 3 data for its Actimmune drug in Friedreich's Ataxia. The analyst thinks that there is only a 50% chance that the data will be successful;. However, he says that the risk/reward ratio is "favorable," based on how he thinks the shares will perform in the wake of the event. He keeps a $29 price target and an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

MTGE

MTGE Investment Corp.

$19.10

-0.3 (-1.55%)

11:40
06/28/17
06/28
11:40
06/28/17
11:40
Options
MTGE Investment attracts a large put buyer »

MTGE Investment attracts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETR

Entergy

$78.25

0.12 (0.15%)

11:36
06/28/17
06/28
11:36
06/28/17
11:36
Hot Stocks
Entergy Louisiana wins approval to build Lake Charles Power Station »

The Louisiana Public…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$52.73

-1.01 (-1.88%)

, V

Visa

$95.57

0.67 (0.71%)

11:35
06/28/17
06/28
11:35
06/28/17
11:35
Hot Stocks
Pacific Crest, Craig-Hallum see promise in 'asset light' PayPal »

Shares of PayPal have…

PYPL

PayPal

$52.73

-1.01 (-1.88%)

V

Visa

$95.57

0.67 (0.71%)

MA

MasterCard

$123.68

0.94 (0.77%)

AMZN

Amazon.com

$976.78

-17.2 (-1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 29

    Jun

TXT

Textron

$47.14

0.69 (1.49%)

11:35
06/28/17
06/28
11:35
06/28/17
11:35
Hot Stocks
Textron names Lisa Atherton president, CEO of Textron Systems »

Textron announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEG

PSEG

$43.70

0.075 (0.17%)

11:30
06/28/17
06/28
11:30
06/28/17
11:30
Conference/Events
PSEG management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 30

    Jun

MITT

AG Mortgage

$18.44

-0.265 (-1.42%)

11:30
06/28/17
06/28
11:30
06/28/17
11:30
Options
AG Mortgage Investment Trust attracts bearish flow »

AG Mortgage Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NGVT

Ingevity

$55.40

1.71 (3.19%)

11:28
06/28/17
06/28
11:28
06/28/17
11:28
Conference/Events
Ingevity management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

SND

Smart Sand

$8.27

0.3 (3.76%)

11:26
06/28/17
06/28
11:26
06/28/17
11:26
Conference/Events
Smart Sand management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

11:25
06/28/17
06/28
11:25
06/28/17
11:25
General news
Equity option flows: call spread demand on S&P e-minis »

Equity option flows: call…

CMCSA

Comcast

$39.25

-0.34 (-0.86%)

11:20
06/28/17
06/28
11:20
06/28/17
11:20
Options
Another large call spread in Comcast »

Another large call spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

$NSD

NASDAQ Market Internals

11:17
06/28/17
06/28
11:17
06/28/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
06/28/17
06/28
11:16
06/28/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AOBC

American Outdoor Brands

$22.95

-0.31 (-1.33%)

11:15
06/28/17
06/28
11:15
06/28/17
11:15
Options
American Outdoor Brands put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

LUV

Southwest

$62.29

0.7799 (1.27%)

11:01
06/28/17
06/28
11:01
06/28/17
11:01
Hot Stocks
Southwest to consolidate Cuba service with focus on Havana »

Southwest Airlines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jul

ALLY

Ally Financial

$21.09

0.095 (0.45%)

11:00
06/28/17
06/28
11:00
06/28/17
11:00
Options
Sale of 5400 Dec 20 calls in Ally Financial likely closes »

Sale of 5400 Dec 20 calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

CBI

CB&I

$22.26

2.2408 (11.19%)

10:58
06/28/17
06/28
10:58
06/28/17
10:58
Hot Stocks
Court corrects error in CB&I opinion »

The Supreme Court of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OMER

Omeros

$22.47

-2.32 (-9.36%)

10:57
06/28/17
06/28
10:57
06/28/17
10:57
Hot Stocks
Omeros lower after short report puts $1 target on shares »

Shares of Omeros are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PWE

Penn West

$1.32

0.001 (0.08%)

10:50
06/28/17
06/28
10:50
06/28/17
10:50
Hot Stocks
Breaking Hot Stocks news story on Penn West 

Penn West trading resumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTI

TechnipFMC

$27.28

0.36 (1.34%)

10:50
06/28/17
06/28
10:50
06/28/17
10:50
Options
TechnipFMC draws a bullish option play »

TechnipFMC draws a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

10:45
06/28/17
06/28
10:45
06/28/17
10:45
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

MRSN

Mersana Therapeutics

10:44
06/28/17
06/28
10:44
06/28/17
10:44
Syndicate
Breaking Syndicate news story on Mersana Therapeutics »

Mersana Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

F

Ford

$11.10

0.02 (0.18%)

10:43
06/28/17
06/28
10:43
06/28/17
10:43
Hot Stocks
Ford sees $142M cost related to Transit recall »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jul

  • 26

    Jul

ZYNE

Zynerba

$18.93

-0.19 (-0.99%)

10:40
06/28/17
06/28
10:40
06/28/17
10:40
Options
Put buyer opens a notable new position in Zynerba Pharmaceuticals »

Put buyer opens a notable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PWE

Penn West

$1.32

0.001 (0.08%)

, OBE

Obsidian Energy

10:35
06/28/17
06/28
10:35
06/28/17
10:35
Hot Stocks
Penn West named in lawsuit due to previously disclosed accounting practices »

Obsidian Energy (OBE),…

PWE

Penn West

$1.32

0.001 (0.08%)

OBE

Obsidian Energy

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CY

Cypress Semiconductor

$13.20

-0.27 (-2.00%)

, AAPL

Apple

$143.73

-2.09 (-1.43%)

10:32
06/28/17
06/28
10:32
06/28/17
10:32
Hot Stocks
Cypress Semi climbs after Barclays gets bullish on iPhone opportunity »

The shares of Cypress…

CY

Cypress Semiconductor

$13.20

-0.27 (-2.00%)

AAPL

Apple

$143.73

-2.09 (-1.43%)

NTDOY

Nintendo

$43.84

-0.41 (-0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

  • 07

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.